An observational study in Meibomian Gland Dysfunction, sponsored by Wenzhou Medical University. Completed at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-09-08.
Sponsored by Wenzhou Medical University · Observational
To evaluate the influence of corneal-aberrations before and after the meibomian gland thermal massage treatment.
62 MGD patients treated with meibomian gland thermal massage once a week for 3 to 4 weeks were recruited.The Ocular Surface Disease Index questionnaire; tear film assessment encompassing tear meniscus height and non-invasive keratograph breakup time ; meibography score,corneal fluorescein staining; the Schirmer I test ; expressible meibomian gland, and quality ,anterior and total corneal aberrations were evaluated before and after treatment.
168 studies on the registry are indexed under Meibomian Gland Dysfunction; 21 are open to participants now.
This study's enrollment of 62 is below the median of 80 across 21 observational studies indexed under Meibomian Gland Dysfunction.
Browse Meibomian Gland Dysfunction studies →Wenzhou Medical University is the lead sponsor of 93 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Diagnosed as meibomian glands dysfunction in our hospital; treatment with thermal massage and expression
Exclusion Criteria:
corneal aberration corneal aberrations
Corneal aberrations were measured with a Pentacam。 The anterior corneal wavefront aberration was expanded with normalized Zernike polynomials.The corneal aberration from 3rd to 6th order were recorded as the root mean square (RMS) for analysis.
Time frame: baseline and 1 week after treatment
This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wenzhou Medical University